ELICITYL is synthesizing 5 new gangliosides (GT1b, GQ1b, GQ1c, GP1c, and GQ3), as well as GD2-9-OAc. Feel free to contact us HERE to express your interest, so we can prioritize production based on the ganglioside you are most interested in and inform you as soon as they are available.